Skip to main content
Premium Trial:

Request an Annual Quote

Merck KGaA Completes Acquisition of Millipore

By Alex Philippidis

NEW YORK (GenomeWeb News) – Merck KGaA has completed its roughly $7 billion acquisition of Millipore and has formed a new life sciences division called EMD Millipore.

Merck agreed to acquire Millipore earlier this year for $107 per share in cash, plus debt. Merck shareholders approved the deal in June, and the transaction gained antitrust clearance from US and European regulatory authorities.

The EMD Millipore division, known as Merck Millipore outside of the US and Canada, will consist of three business units — Bioscience, Lab Solutions, and Process Solutions. The division will be lead by Bernd Reckmann, who has been with Merck since 1986 and currently serves as head of its Chemicals Business Sector and a member of the firm's executive board.

"With today's launch of EMD Millipore, we are creating a world-class partner for the Life Science sector, with a comprehensive product offering and enhanced global scale and innovative power," Karl-Ludwig Kley, chairman of the Merck Executive Board, said in a statement. "We will now move quickly to bring together the expertise and complementary capabilities of both Merck and Millipore employees to capture the significant opportunities in the high-growth, high-margin market segments such as bio-research and bio-production."

EMD Millipore will have around 10,000 employees in 64 countries, and it has pro forma revenues of roughly $2.9 billion in fiscal-year 2009.

Merck said that it expects the majority of integration decisions to be made by the end of this year. It has previously said that it expects the combined business to generate annual cost synergies of around $100 million within three years of the closing of the transaction.

Millipore CEO Martin Madaus is not joining the newly combined firm, but he will serve as an advisor during the integration process. Millipore CFO Charles Wagner is also leaving the company.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.